Stopping diabetes before it starts

Sweetch, an Israeli digital health startup, is on a mission to make the world a healthier place. Its first undertaking: to prevent people who are at risk for diabetes from developing the disease. More than 86 million US and 63 million European adults have a blood-sugar level that is higher than normal but not yet high enough to be considered diabetes, according to statistics. This pre-diabetic population will most likely develop Type 2 diabetes without intervention. And that’s why health professionals and venture capitalists are celebrating Sweetch’s recent Series A financing round of $3.5 million to advance its technology designed to identify and coach individuals at risk of developing diabetes and other chronic conditions. The round was led by Philips and the Jerusalem-based OurCrowd equity crowdfunding platform, with participation from prior investors Pontifax and Lionbird. Read more...